Delivery Order SPE2DB20D1047-SPE2DB25FF73H

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PEGASYS 180 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a firm fixed price of $2,752.23 and a performance period ending on June 9, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEGASYS 180 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $2,752.23. The contract has a firm fixed price pricing type and is set to expire on May 19, 2025. This contract is not a set-aside and is open to full and open competition. AmerisourceBergen...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PEGASYS 180 MCG/0.5 ML SYRINGE 0.5ML. The $4,814.31 firm fixed-price contract has a performance period through July 7, 2025 and is not set aside for any particular business type. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a comprehensive global...

The Defense Logistics Agency awarded a $5,380.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 180 mcg/0.5 ml syringes of peginterferon alfa-2b, also known as PEGASYS. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August 9-10, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for hepatitis C treatment medication supports the DLA's mission to provide...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PEGASYS 180 MCG/ML VIALML. The order has a ceiling value of $6,973.68 and is a firm fixed-price contract type. The ultimate completion date for this contract is August 8, 2024. This contract is not associated with any set-aside designations. AmerisourceBergen Drug Corp holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support...

Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Valued at $5,380.54, this order is for the delivery of 4562823931 units of Pegasys 180 mcg/0.5 ml syringes to the place of performance in Conshohocken, Pennsylvania by November 16, 2023. No set aside designation was applied to this award. As a prime contractor supporting DLA Troop Support...

The Defense Logistics Agency Troop Support Medical awarded a $4,024 firm fixed price delivery order to Amerisourcebergen Drug Corp for 180 mcg/ml vials of pegylated interferon alfa-2a, also known as PEGASYS, to be delivered to a location in Conshohocken, Pennsylvania on August 10-11, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor. No subcontractors or set aside designations were identified. This order is likely...

This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule provides 14,785.51 dollars' worth of peglicatase injection vials for the Richmond Veterans Affairs Medical Center. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded the firm fixed price contract to Horizon Therapeutics USA Inc. on March 24, 2021, with a completion date of February 1, 2022. No set-aside designation was used. The contract utilizes Master...

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,072.25, is for the delivery of PEGASYS 180 MCG/ML VIALML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...

This delivery order, awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, is for the delivery of five hundred eight dollars worth of Repatha 140 mg/ml syringes. The order has a firm fixed price and period of performance through October 16, 2023. To be delivered to the specified location in Conshohocken, Pennsylvania, the syringes will support DLA Troop Support Medical's mission to provide quality medical supplies to military treatment facilities...